165 related articles for article (PubMed ID: 29426913)
1. A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors.
Mateen R; Ali MM; Hoare T
Nat Commun; 2018 Feb; 9(1):602. PubMed ID: 29426913
[TBL] [Abstract][Full Text] [Related]
2. High-throughput assays for promiscuous inhibitors.
Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
[TBL] [Abstract][Full Text] [Related]
3. ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.
Shi S; Fu L; Yi J; Yang Z; Zhang X; Deng Y; Wang W; Wu C; Zhao W; Hou T; Zeng X; Lyu A; Cao D
Nucleic Acids Res; 2024 Jul; 52(W1):W439-W449. PubMed ID: 38783035
[TBL] [Abstract][Full Text] [Related]
4. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
McGovern SL; Caselli E; Grigorieff N; Shoichet BK
J Med Chem; 2002 Apr; 45(8):1712-22. PubMed ID: 11931626
[TBL] [Abstract][Full Text] [Related]
5. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
[TBL] [Abstract][Full Text] [Related]
6. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
[TBL] [Abstract][Full Text] [Related]
7. Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.
Engel BJ; Constantinou PE; Sablatura LK; Doty NJ; Carson DD; Farach-Carson MC; Harrington DA; Zarembinski TI
Adv Healthc Mater; 2015 Aug; 4(11):1664-74. PubMed ID: 26059746
[TBL] [Abstract][Full Text] [Related]
8. Transfer printing of transfected cell microarrays from poly(ethylene glycol)-oleyl surfaces onto biological hydrogels.
Yamaguchi S; Komiya S; Matsunuma E; Yamahira S; Kihara T; Miyake J; Nagamune T
Biotechnol Bioeng; 2013 Dec; 110(12):3269-74. PubMed ID: 23893595
[TBL] [Abstract][Full Text] [Related]
9. High-throughput mass spectrometric cytochrome P450 inhibition screening.
Lim KB; Ozbal CC; Kassel DB
Methods Mol Biol; 2013; 987():25-50. PubMed ID: 23475665
[TBL] [Abstract][Full Text] [Related]
10. Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.
Matlock MK; Hughes TB; Dahlin JL; Swamidass SJ
J Chem Inf Model; 2018 Aug; 58(8):1483-1500. PubMed ID: 29990427
[TBL] [Abstract][Full Text] [Related]
11. High-throughput identification of promiscuous inhibitors from screening libraries with the use of a thiol-containing fluorescent probe.
McCallum MM; Nandhikonda P; Temmer JJ; Eyermann C; Simeonov A; Jadhav A; Yasgar A; Maloney D; Arnold AL
J Biomol Screen; 2013 Jul; 18(6):705-13. PubMed ID: 23446699
[TBL] [Abstract][Full Text] [Related]
12. Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening.
Mazzini F; Nuti E; Petri A; Rossello A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):756-62. PubMed ID: 21397574
[TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors.
Giannetti AM; Koch BD; Browner MF
J Med Chem; 2008 Feb; 51(3):574-80. PubMed ID: 18181566
[TBL] [Abstract][Full Text] [Related]
14. High-throughput assay development for combined in vitro toxicity screening of hit compounds and their metabolites in early drug-discovery stage.
Siricilla S
Bioanalysis; 2017 Jul; 9(13):959-961. PubMed ID: 28708435
[No Abstract] [Full Text] [Related]
15. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
Venkatraman J; Bhat J; Solapure SM; Sandesh J; Sarkar D; Aishwarya S; Mukherjee K; Datta S; Malolanarasimhan K; Bandodkar B; Das KS
J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722
[TBL] [Abstract][Full Text] [Related]
16. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Seidler J; McGovern SL; Doman TN; Shoichet BK
J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
[TBL] [Abstract][Full Text] [Related]
17. Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry.
Meng J; Lai MT; Munshi V; Grobler J; McCauley J; Zuck P; Johnson EN; Uebele VN; Hermes JD; Adam GC
J Biomol Screen; 2015 Jun; 20(5):606-15. PubMed ID: 25681434
[TBL] [Abstract][Full Text] [Related]
18. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
[TBL] [Abstract][Full Text] [Related]
19. Frequent hitters: nuisance artifacts in high-throughput screening.
Yang ZY; He JH; Lu AP; Hou TJ; Cao DS
Drug Discov Today; 2020 Apr; 25(4):657-667. PubMed ID: 31987936
[TBL] [Abstract][Full Text] [Related]
20. Electrochemical antioxidant screening based on a chitosan hydrogel.
Fu L; Wang A; Lyv F; Lai G; Zhang H; Yu J; Lin CT; Yu A; Su W
Bioelectrochemistry; 2018 Jun; 121():7-10. PubMed ID: 29306186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
